Skip to main content
. 2023 Mar 17;16(3):455. doi: 10.3390/ph16030455
ABC abciximab
AC anticoagulant drugs
ACE acenocoumarol
ACL combination of acetylsalicylic acid and clopidogrel
ADRs adverse reactions
AF atrial fibrillation
API apixaban
ARG argatroban
BEM bemiparin
BIV bivalirudin
CER certoparin
CI confidence interval
CIL cilostazol
CLO clopidogrel
DAB dabigatran
DAL dalteparin
DAN danaparoid
DAS combination of dipyridamole and acetylsalicylic acid
DIP dipyridamole
DOACs direct oral anticoagulant drugs
EDO edoxaban
EEA European Economic Area
EMA European Medicines Agency
ENO enoxaparin
EPT eptifibatide
EV EudraVigilance
FLU fluindione
FON fondaparinux
HEP unfractionated heparin
ICSR Individual Case Safety Report
LEP lepirudin
LMWHs low molecular weight heparins
ME medication errors
MedDRA Medical Dictionary for Regulatory Activities
NAD nadroparin
NR/NS not recovered/not resolved
PRA prasugrel
PT preferred term
RIV rivaroxaban
ROR reporting odds ratio
SOC system organ classes
TCL ticagrelor
TIC ticlopidine
TIN tinzaparin
TIR tirofiban
VKAs vitamin K antagonists
WAR warfarin